Südzucker AG : Correction on heavy volume
April 07, 2017 at 03:46 am
By
Entry price | Target | Stop-loss | Potential |
---|
€20.82 |
€19 |
€22 |
+8.74% |
---|
After a downgrade by Goldman Sachs and a reduction in the bank's target price from 23 € to 18 € shares in Suedzucker are down substantially this week. In light of the movement's force a near-term turnaround in the share price is unlikely. Rather, a continuation of the downward movement towards 19 € should be priviledged by investors.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths● Share prices are approaching a strong support area in daily data, which offers good timing for investors.
● As regards fundamentals, the enterprise value to sales ratio is at 0.78 for the current period. Therefore, the company is undervalued.
● For the past twelve months, EPS forecast has been revised upwards.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses● According to forecast, a sluggish sales growth is expected for the next fiscal years.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.